Literature DB >> 33269612

On Dimensionality, Measurement Invariance, and Suitability of Sum Scores for the PHQ-9 and the GAD-7.

Jan Stochl1,2,3, Eiko I Fried4, Jessica Fritz1, Tim J Croudace5, Debra A Russo1, Clare Knight1, Peter B Jones1,2, Jesus Perez1,2.   

Abstract

In psychiatry, severity of mental health conditions and their change over time are usually measured via sum scores of items on psychometric scales. However, inferences from such scores can be biased if psychometric properties such as unidimensionality and temporal measurement invariance for instruments are not met. Here, we aimed to evaluate these properties for common measures of depression (Patient Health Questionnaire-9) and anxiety (Generalized Anxiety Disorder Assessment-7) in a large clinical sample (N = 22,362) undergoing psychotherapy. In addition, we tested consistency in dimensionality results across different methods (parallel analysis, factor analysis, explained common variance, the partial credit model, and the Mokken model). Results showed that while both Patient Health Questionnaire-9 and Generalized Anxiety Disorder Assessment-7 are multidimensional instruments with highly correlated factors, there is justification for sum scores as measures of severity. Temporal measurement invariance across 10 therapy sessions was evaluated. Strict temporal measurement invariance was established in both scales, allowing researchers to compare sum scores as severity measures across time.

Entities:  

Keywords:  GAD-7; PHQ-9; dimensionality; measurement invariance; sum scores

Mesh:

Year:  2020        PMID: 33269612     DOI: 10.1177/1073191120976863

Source DB:  PubMed          Journal:  Assessment        ISSN: 1073-1911


  6 in total

1.  Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample.

Authors:  Martin Brattmyr; Martin Schevik Lindberg; Stian Solem; Odin Hjemdal; Audun Havnen
Journal:  BMC Psychiatry       Date:  2022-07-11       Impact factor: 4.144

2.  Longitudinal assessment of depression during the first year after stroke: Dimensionality and measurement invariance.

Authors:  Liming Dong; Linda S Williams; Emily Briceno; Lewis B Morgenstern; Lynda D Lisabeth
Journal:  J Psychosom Res       Date:  2021-12-02       Impact factor: 4.620

3.  Commentary: The construct validity of 'camouflaging' in autism: psychometric considerations and recommendations for future research - reflection on Lai et al. (2020).

Authors:  Zachary J Williams
Journal:  J Child Psychol Psychiatry       Date:  2021-06-17       Impact factor: 8.982

4.  Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic.

Authors:  Mark Shevlin; Sarah Butter; Orla McBride; Jamie Murphy; Jilly Gibson-Miller; Todd K Hartman; Liat Levita; Liam Mason; Anton P Martinez; Ryan McKay; Thomas Va Stocks; Kate M Bennett; Philip Hyland; Frédérique Vallieres; Carmen Valiente; Carmelo Vazquez; Alba Contreras; Vanesa Peinado; Almudena Trucharte; Marco Bertamini; Anna Panzeri; Giovanni Bruno; Umberto Granziol; Giuseppe Mignemi; Andrea Spoto; Giulio Vidotto; Richard P Bentall
Journal:  BMC Psychiatry       Date:  2022-03-01       Impact factor: 3.630

5.  Ontario COVID-19 and Kids Mental Health Study: a study protocol for the longitudinal prospective evaluation of the impact of emergency measures on child and adolescent mental health during the COVID-19 pandemic.

Authors:  Daphne J Korczak; Katherine T Cost; Kaitlyn LaForge-MacKenzie; Evdokia Anagnostou; Catherine S Birken; Alice Charach; Suneeta Monga; Jennifer Crosbie
Journal:  BMJ Open       Date:  2022-03-02       Impact factor: 2.692

6.  Freely Generated Word Responses Analyzed With Artificial Intelligence Predict Self-Reported Symptoms of Depression, Anxiety, and Worry.

Authors:  Katarina Kjell; Per Johnsson; Sverker Sikström
Journal:  Front Psychol       Date:  2021-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.